MYLAN INC. Derivative Instruments, Loss Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing
MYLAN INC. reported Derivative Instruments, Loss Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing of $5.71 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-04-27.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeInstrumentsLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTesting · last filed 2012-04-27
- MYLAN INC. derivative instruments, loss recognized in income, ineffective portion and amount excluded from effectiveness testing for the quarter ending 2012-03-31 was $5.71M, a 16697.06% increase year-over-year.
- MYLAN INC. derivative instruments, loss recognized in income, ineffective portion and amount excluded from effectiveness testing for the quarter ending 2011-09-30 was $12.16M.
- MYLAN INC. derivative instruments, loss recognized in income, ineffective portion and amount excluded from effectiveness testing for the quarter ending 2011-06-30 was $5.05M, a 304.32% increase year-over-year.
- MYLAN INC. derivative instruments, loss recognized in income, ineffective portion and amount excluded from effectiveness testing for the quarter ending 2011-03-31 was $34.00K.
| Period end | Derivative Instruments, Loss Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing 3 month | Derivative Instruments, Loss Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing 6 month | Derivative Instruments, Loss Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing 9 month |
|---|---|---|---|
| 2012-03-31 | $5.71M 10-Q · filed 2012-04-27 | ||
| 2011-09-30 | $12.16M 10-Q · filed 2011-10-26 | $17.21M derived: sum of 2 quarters · filed 2011-10-26 | $17.25M 10-Q · filed 2011-10-26 |
| 2011-06-30 | $5.05M 10-Q · filed 2011-07-27 | $5.09M 10-Q · filed 2011-07-27 | |
| 2011-03-31 | $34.00K 10-Q · filed 2012-04-27 | ||
| 2010-09-30 | -$4.97M 10-Q · filed 2011-10-26 | -$3.72M derived: sum of 2 quarters · filed 2011-10-26 | -$3.72M 10-Q · filed 2011-10-26 |
| 2010-06-30 | $1.25M 10-Q · filed 2011-07-27 | $1.25M 10-Q · filed 2011-07-27 |